Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1983-02-18
1985-08-20
Rollins, Alton D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
2602455, 514212, 514230, 514232, 514234, 514237, 514326, 514340, 514384, 544132, 546210, 546276, 548263, 548265, 548266, A61K 3141, C07D24914, C07D40110, C07D41310
Patent
active
045365083
ABSTRACT:
The invention relates to compounds of the general formula (I) ##STR1## and physiologically acceptable salts, hydrates and bioprecursors thereof, which show pharmacological activity as selective histamine H.sub.2 -antagonists.
REFERENCES:
patent: 4128658 (1978-12-01), Price et al.
patent: 4323566 (1982-04-01), Clitherow et al.
Bradshaw John
Clitherow John W.
Hayes Roger
Judd Duncan B.
Mackinnon John W. M.
Glaxo Group Limited
Rollins Alton D.
LandOfFree
Triazoleamine derivatives having histamine H.sub.2 -antagonist p does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazoleamine derivatives having histamine H.sub.2 -antagonist p, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazoleamine derivatives having histamine H.sub.2 -antagonist p will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-561277